Your browser doesn't support javascript.
loading
Remarkably different results between two studies from North America on genomic mutations and sensitivity to DNA demethylating agents for myelodysplastic syndromes.
Wang, Guiping; Guo, Shanshan; Xiao, Huashi; Zong, Liang; Asakawa, Tetsuya; Abe, Masanobu; Hu, Wenqing; Ji, Jiafu.
Afiliação
  • Wang G; Medical Research Center, Clinical Medical College of Yangzhou University (Northern Jiangsu People's Hospital), Yangzhou 225001, China.
  • Guo S; Medical Research Center, Clinical Medical College of Yangzhou University (Northern Jiangsu People's Hospital), Yangzhou 225001, China.
  • Xiao H; Medical Research Center, Clinical Medical College of Yangzhou University (Northern Jiangsu People's Hospital), Yangzhou 225001, China.
  • Zong L; Medical Research Center, Clinical Medical College of Yangzhou University (Northern Jiangsu People's Hospital), Yangzhou 225001, China.
  • Asakawa T; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • Abe M; Department of Gastrointestinal Surgery, Clinical Medical College of Yangzhou University (Northern Jiangsu People's Hospital), Yangzhou 225001, China.
  • Hu W; Department of Neurosurgery, Hamamatsu University School of Medicine, Handayama, Hamamatsu-city, Shizuoka 431-3192, Japan.
  • Ji J; Division for Health Service Promotion, University of Tokyo Hospital, Tokyo 113-003, Japan.
Chin J Cancer Res ; 29(6): 587-588, 2017 Dec.
Article em En | MEDLINE | ID: mdl-29353982

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article